7th Annual IMPACCT: RWE
Event Sep 18 - Sep 19, 2019
Aloft Boston Seaport District 401-403 D St, Boston, MA 02210
Returning for its 7th year, IMPACCT: RWE provides top innovators and leaders in the real world evidence space with a comprehensive industry forum dedicated to supporting and advancing the generation and utilization of real world evidence across drug life cycle, from clinical development to commercialization. Join your peers and leading experts for a collaborative open discussion aiming to tackle key challenges to accelerate the meaningful implementation of real world evidence approaches to enhance clinical R&D outcomes, drive patient-centricity, and maximize the success of launch and commercialization activities. Real world evidence is at the root of an ongoing and critical transformation in medical care. By incorporating data from the real world into their development programs, drug developers are now able to drive more patient-facing outcomes, by supporting it with effective evidence-based decision-making across the product life cycle. At a point of increasing maturity, regulatory acceptance, and growing innovation, these are exciting times for all stakeholders actively involved in the efforts to advance the effective utilization and generation of real world evidence. Leading experts in the space will be tackling questions and sharing the latest case-studies around the use of RWE in: • Patient identification • Clinical trial design • Historic control arms • Outcomes research • Observational research • Post-launch safety studies • Defining medical affairs strategy • Value generation across the product life cycle • Regulatory decision-making • Label extensions • Patient access … and more. Join them at this collaborative discussion platform that aims to bring together stakeholders from functions across clinical development, HEOR, regulatory and medical affairs, epidemiology and RWE, to overcome key challenges to define and implement a meaningful evidence generation plan that can effectively enhance clinical R&D, support regulatory submission and decision-making, and ultimately drive commercial success.
Like what you just read? You can find similar content on the communities below.Analysis & Separations Applied Sciences Biopharma Cell Science Diagnostics Drug Discovery Informatics Immunology & Microbiology
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE